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mitral valve calciﬁcation and 62% aortic calciﬁcation. High desphospho-
uncarboxylated MGP (dp-ucMGP) concentrations, reﬂecting poor vita-
min K status, were borderline signiﬁcantly (p = 0.08) associated with
more CAC (RRSD: 1.07; 95%CI: 0.99–1.15) and calciﬁed areas with an
ORSD of 1.49 (95%CI: 0.95–2.35, p = 0.09) for 4 calciﬁed areas versus
no calciﬁed areas adjusted for age, follow-up time, smoking, BMI, blood
pressure and HDL-cholesterol (Table 1).
High total-uncarboxylated MGP (t-ucMGP) concentrations
were borderline signiﬁcantly associated with fewer calciﬁed areas
(ORSD(4 vs 0 areas) 0.63; 95%CI: 0.36–1.10, p = 0.10). However, circulat-Observational studies showed that high vitaminK intake is associated
with reduced coronary artery calciﬁcation (CAC) and cardiovascular
disease (CVD) risk [1,2]. These effects are thought to be mediated by
increased activation of the vitamin K-dependent protein matrix-Gla
protein (MGP) [3]. However, only few studies investigated the relation
of different MGP species with CAC and none of these studies were
performed in the general population [4]. The aim of this prospective
study is to investigate the association between circulating MGP species
and vascular calciﬁcation among healthy women.
This study was performed in a prospective cohort of 571 women
aged 57.3 (±5.2) years, described in detail elsewhere [5,6]. Baseline
plasmaMGP levelsweremeasured by ELISA techniques [7]. Calciﬁcation
was measured in the coronary arteries, aortic valve, mitral valve, and
aortic arch by multi-detector computed tomography after 8.5 (±1.3)
years of follow-up and graded as present or absent. CAC was present if
Agatston score was ≥10. The calciﬁcation score was calculated as the
sum of the calciﬁed areas. Modiﬁed Poisson regressionwas used to esti-
mate relative risks (RR) for the association between MGP and CAC.
Multinomial logistic regression was used to estimate odds ratios (OR)
for the association between MGP or vitamin K with calciﬁed areas,
since this is an ordinal outcome.Sciences and Primary Care,
85500, 3508 GA Utrecht, The
9.
almeijer).
liability and freedom from bias
td. All rights reserved.In this population, 43% had CAC, 22% aortic valve calciﬁcation, 11%
ing t-ucMGP was not associated with the presence of CAC (RRSD: 1.06;
95%CI: 0.98–1.16, p = 0.17). Thiswasdue to thepresence of a nonlinear
relation as indicated by a signiﬁcant quadratic term (p = 0.03). Spline
regression showed evidence of a U-shaped relation (p = 0.13) between
t-ucMGP and coronary calciﬁcation with lower presence of CAC up
to 3.2 nM, but increasing RRs at higher levels (Fig. 1). Circulating
desphosho-carboxylated MGP (dp-cMGP) was not associated with
calciﬁcation.
After adjustment, high phylloquinone intake was not associated
with the number of calciﬁed areas ORSD(4 vs 0 areas) 1.14 (95%CI:
0.72–1.81, p = 0.57). However, high menaquinone intake was sig-
niﬁcantly associated with decreased odds of having four calciﬁed
areas. Per SD increase inmenaquinone, the odds of having four calciﬁed
areas was 61% lower (OR 0.39; 95%CI: 0.21–0.74, p = 0.004; Table 1).
Both high phylloquinone (βSD:−0.043; 95%CI: −0.070; −0.016) and
menaquinone (βSD: −0.032; 95%CI: −0.059; −0.009) intake were
associated with lower dp-ucMGP concentrations adjusted for age, BMI
and smoking.
This prospective study shows that high dp-ucMGP concentrations
may be associated with higher risk of CAC and more calciﬁed areas.
High t-ucMGP concentrations seem to be associatedwith fewer calciﬁed
areas. Furthermore, high menaquinone intake was associated with
fewer calciﬁed areas and lower dp-ucMGP concentrations.
A previous study in this study population showed that high
menaquinone intake, but not phylloquinone, was associated with re-
duced CAC [1]. We now show that high menaquinone intake is also
associated with fewer calciﬁed areas. Phylloquinone intake, however,
was not associated with calciﬁcation. These results are in line with pre-
vious observational studies on vitamin K intake in relation to CAC and
coronary heart disease [1,2,8]
Table 1
Relative risks (95%-CI) of circulating levels of MGP species with coronary calciﬁcation and odds ratios (95%-CI) of MGP species, menaquinone and phylloquinonewith calciﬁcation among
571 post-menopausal womena.
CAC calciﬁed areas
0 1 2 3 4
N = 249 N = 138 N = 179 N = 165 N = 55 N = 22
RRb 95%CI ORb 95%CI ORb 95%CI ORb 95%CI ORb 95%CI
dp-ucMGP
Model 1c 1.06 0.99–1.13 1 1.33 1.00–1.76 1.33 0.99–1.79 1.50 1.06–2.13 1.49 0.98–2.26
Model 2d 1.07 0.99–1.15 1 1.28 0.95–1.72 1.25 0.91–1.71 1.47 1.02–2.12 1.49 0.95–2.35
t-ucMGP
Model 1c 1.08 0.99–1.18 1 0.89 0.70–1.13 1.20 0.94–1.55 1.14 0.81–1.59 0.75 0.44–1.27
Model 2d 1.06 0.98–1.16 1 0.84 0.65–1.09 1.08 0.83–1.41 1.02 0.72–1.46 0.63 0.36–1.10
dp-cMGP
Model 1c 1.01 0.93–1.10 1 1.27 0.99–1.64 1.43 1.09–1.86 1.13 0.78–1.63 1.09 0.65–1.83
Model 2d 1.01 0.92–1.11 1 1.22 0.94–1.59 1.33 1.00–1.76 1.05 0.71–1.56 1.07 0.61–1.86
phylloquinone
Model 1c 1 0.83 0.66–1.04 0.95 0.75–1.21 0.84 0.60–1.19 1.17 0.75–1.82
Model 2d 1 0.83 0.66–1.06 0.94 0.73–1.21 0.83 0.59–1.18 1.14 0.72–1.81
menaquinone
Model 1c 1 0.86 0.69–1.08 0.90 0.71–1.14 0.93 0.67–1.29 0.35 0.20–0.64
Model 2d 1 0.88 0.69–1.11 0.93 0.72–1.20 0.94 0.67–1.32 0.39 0.21–0.74
MGP, Matrix Gla protein; dp-ucMGP, desphospho-uncarboxylated MGP; dp-cMGP, desphospho carboxylated MGP; t-ucMGP, total uncarboxylated MGP.
a Modiﬁed Poisson regressionmodel was used to estimate relative risks (RR) for the association betweenMGP species and presence of CAC.Multinomial logistic regressionwas used to
estimate odds ratios (OR) for the association betweenMGP species or vitaminK intakewith calciﬁed areas. Thegroupwith one to four calciﬁedareaswas comparedwith the groupwithout
calciﬁcation in any area.
b All RRs and ORs are expressed per SD of the mean.
c Adjusted for age, follow up time.
d Adjusted for age, follow up time, smoke habits, BMI, blood pressure and HDL-cholesterol.
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ucMGP concentrations and CAC and more calciﬁed areas. This is in line
with the results of our cross-sectional study showing a borderlineFig. 1. Association between t-ucMGP circulating levels and relative risk of CAC modelled
continuously using splines; RR(—) with 95%CI in grey.signiﬁcant association between high dp-ucMGP and high CAC [6]. Simi-
larly, previous studies reported higher dp-ucMGP concentrations
among patients with diseases characterized by vascular calciﬁcation
[4]. However, in another cross-sectional study among healthy adults,
no association between dp-ucMGP and CAC was found [8]. Because this
form of MGP has very low afﬁnity for deposited calcium salts, the inﬂu-
ence of vitamin K intake is directly observed in the circulation. Previous
studies have shown that dp-ucMGP could be a sensitive marker of vita-
min K intake and statuswith low concentrations reﬂecting a high vitamin
K status or intake [3]. In line with these studies [4] we found that low
dp-ucMGP concentrations were associated with high phylloquinone
and menaquinone intake. Altogether, these results suggest that low
dp-ucMGP concentrations could explain the reduced risk of CAC with
high vitamin K intake.
Similar to high-risk populations [4], we found that low t-ucMGP
levels were associated with more calciﬁed areas. Due to the presence
of a U-shaped relation between t-ucMGP and CAC we did not ﬁnd an
association using linear regression. However, similar to the association
with number of calciﬁed areas, spline regression also showed slightly
lower RRs for CAC up to 3.2 nM t-ucMGP, which increased at higher
concentrations. We assume that t-ucMGP mainly consists of phosphor-
ylated ucMGP species. The phosphoserines equip the molecule with
strong calcium-binding groups irrespective of its Gla content and this
fraction has a strong afﬁnity to bind to vascular calciﬁcations, resulting
in a decrease in the circulating levels of t-ucMGP. This explains the
lower t-ucMGP concentrations at higher CAC [9]. Therefore, t-ucMGP
may act differently in persons with or without calciﬁcation.
A limitation of our study is that the dp-ucMGP and dp-cMGP levels
were low compared to a healthy reference population [7]. This could
be due to the possible degradation of MGP in our samples, because the
samples were stored for a long time. However, we compared the levels
with those measured previously [6] and found reasonable correlation
coefﬁcients of 0.67 for dp-ucMGP and 0.51 for t-ucMGP. We therefore
assume that degradation of MGP did not substantially affect the ranking
of individuals and did not systematically bias the associationswe found.
Taken together, high dp-ucMGP concentrations, reﬂecting a poor
vitamin K status, may be associated with more calciﬁcation, which
e170 G.W. Dalmeijer et al. / International Journal of Cardiology 168 (2013) e168–e170could explain the reduced CAC risk with high vitamin K intake. High
t-ucMGP concentrations seem to be associatedwith fewer calciﬁed areas.
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